ImmunoScape Revenue and Competitors
Estimated Revenue & Valuation
- ImmunoScape's estimated annual revenue is currently $4.3M per year.
- ImmunoScape's estimated revenue per employee is $77,500
- ImmunoScape's total funding is $39M.
Employee Data
- ImmunoScape has 56 Employees.
- ImmunoScape grew their employee count by 4% last year.
ImmunoScape's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | CFO | Reveal Email/Phone |
4 | COO | Reveal Email/Phone |
5 | VP, Discovery | Reveal Email/Phone |
6 | Research Officer | Reveal Email/Phone |
7 | Research Officer | Reveal Email/Phone |
8 | Research Officer | Reveal Email/Phone |
9 | VP Strategy | Reveal Email/Phone |
10 | VP, Operations and Technology Development | Reveal Email/Phone |
ImmunoScape Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.9M | 63 | -24% | $15M | N/A |
#2 | $20M | 129 | -16% | $150M | N/A |
#3 | $3.7M | 48 | -6% | $53M | N/A |
#4 | $5.4M | 35 | -8% | N/A | N/A |
#5 | $3.6M | 23 | -18% | N/A | N/A |
#6 | $3.4M | 22 | 0% | N/A | N/A |
#7 | $5.4M | 35 | 6% | N/A | N/A |
#8 | $7.1M | 46 | -26% | N/A | N/A |
#9 | $36.1M | 233 | 4% | N/A | N/A |
#10 | $3.1M | 20 | -61% | N/A | N/A |
What Is ImmunoScape?
ImmunoScape enables the characterization of a patient's immune profile at unprecedented resolution. Our assays provide a view into the immune system in action, directly observing T cell phenotype & function with simultaneous tracking of TCR-antigen binding. Our platform delivers key insights on antigen-specific T cells in studies of immune checkpoint blockade, therapeutic and prophylactic vaccines, and T cell therapy, empowering researchers and drug developers. Discover novel vaccine, antibody, or cell therapy targets Evaluate treatment outcomes through longitudinal studies Design successful clinical trials through efficient patient enrollment Uncover combinations of predictive biomarkers of disease or treatment efficacy Demonstrate proof-of-mechanism in tissues of interest To learn more, visit us at immunoscape.com and follow us on Twitter @immunoscape.
keywords:N/A
$39M
Total Funding
56
Number of Employees
$4.3M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ImmunoScape News
ImmunoScape, a biotech company which specializes in cancer treatment, has raised $14 million fundraising round. ... Take 1 minute to subscribe and you'll get this story immediately, plus: Already a subscriber? Sign in 52 weekly issues Subscriber-only digital content every business day, plus f ...
ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights into the human immune system, today announced it has completed a $14 million fundraising round led by existing investors Anzu Partners, University of Tokyo Edge Capital Partners (UTEC) and ne ...
ImmunoScape, a Singapore and San Diego, CA-based biotech company with an immunomics-based technology platform that provides novel insights into the human immune system, completed a $14m funding round. The round, which brought total funding to $25m, was led by existing investors Anzu Partners, U ...
Other Companies in Singapore
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.1M | 56 | 8% | N/A |
#2 | $7.1M | 56 | -8% | N/A |
#3 | $6.6M | 56 | 0% | N/A |
#4 | $6.6M | 56 | -28% | $27M |
#5 | $7.3M | 56 | 6% | N/A |